Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013021
Filing Date
2020-11-06
Accepted
2020-11-06 08:02:43
Documents
56
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20200930x10q.htm   iXBRL 10-Q 1323278
2 EX-31.1 glyc-20200930xex31d1.htm EX-31.1 17036
3 EX-31.2 glyc-20200930xex31d2.htm EX-31.2 16857
4 EX-32.1 glyc-20200930xex32d1.htm EX-32.1 9464
  Complete submission text file 0001558370-20-013021.txt   5198054

Data Files

Seq Description Document Type Size
5 EX-101.SCH glyc-20200930.xsd EX-101.SCH 30441
6 EX-101.CAL glyc-20200930_cal.xml EX-101.CAL 37029
7 EX-101.DEF glyc-20200930_def.xml EX-101.DEF 149290
8 EX-101.LAB glyc-20200930_lab.xml EX-101.LAB 293378
9 EX-101.PRE glyc-20200930_pre.xml EX-101.PRE 275265
10 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20200930x10q_htm.xml XML 899258
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 201292461
SIC: 2834 Pharmaceutical Preparations